Regentis Biomaterials Ltd
Officers & Directors
Dr. Ehud Geller, age 78, has served as Chairman and Chief Executive Officer since December 31, 2025. His pharmaceutical leadership experience includes positions at PRF Technologies Ltd., Medica Venture Partners, Teva Pharmaceutical Industries Ltd., and Interpharm Laboratories, Ltd. He holds a B.Sc. in Chemical Engineering, an MBA from Columbia University/Drexel Institute, and a Ph.D. in Pharmaceutical/Chemical Engineering from Drexel Institute.
Arie Gordashnikov, age 42, has been Chief Accounting Officer since February 2026. He previously served as Chief Financial Officer from October 2022 to January 2026. Gordashnikov has over 15 years of experience in accounting, auditing, and finance. He holds an MBA from Tel Aviv University, a B.A. from Hebrew University of Jerusalem, and has been a licensed CPA since 2012.
Ori Gon, age 44, was appointed Chief Financial Officer in February 2026. He has more than 15 years of financial leadership experience in public and private enterprises and the medical technology sector, with previous roles at Tactile Mobility, ReWalk Robotics, Inc. (now Lifeward Ltd.), On Track Innovations Ltd., and KPMG Israel. Gon holds a Bachelor's Degree in Accounting and Finance from Hebrew University of Jerusalem.
Dr. Galit Reske, age 54, was appointed Chief Medical Officer in February 2026, with an anticipated start date in April 2026. From 2017 to 2026, she served as Director of Clinical Operations at CartiHeal.
Regentis Biomaterials Ltd currently has 8 employees.
|
